Antisense Therapeutics Limited (ASX code: ANP) is an Australian publicly traded pharmaceutical drug discovery and development company whose mission is to create, develop and commercialise novel antisense therapeutics.
Antisense Therapeutics' strategy is:
• to create antisense drugs for diseases where there are large and/or poorly met markets, in collaboration with Antisense Therapeutics’ technology and research partners
• to out-source preclinical and clinical testing of the candidate drugs to expert contractors
• to commercialise the drugs that are shown to be successful in pre-clincal and/or clinical testing by entering into licensingdeals or other partnerships with major pharmaceutical companies.
Market Reports /
by Melissa Darmawan -
2 years ago
11 May 2022 - Wall St closed mixed lifted by information tech and M&A news in the biotech sector as dip buyers emerge ahead of the next CPI print. Shanghai stocks bucked the trend …
Market Reports /
by -
12 years ago
31 Jan 2013 - ASX looks to pause from gains. Rio Tinto Limited’s (ASX:RIO) new CEO Sam Walsh resigns as a non-executive director of Seven West Media Limited (ASX:SWM).
